Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00504283 · ClinicalTrials.gov registry record · NA
An Analgesia Protocol for Acute Renal Colic in the Emergency Department
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00504283 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 45 participants.
The verdict
NCT00504283, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
An analgesia protocol for acute renal colic will lead to faster significant reductions in pain than prior practice.
Interventions
- DRUG Morphine
- DRUG Toradol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00504283
The ClinicalTrials.gov registry entry for NCT00504283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Morphine is the first listed.
NCT00504283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00504283 about?
NCT00504283 is a clinical study titled "An Analgesia Protocol for Acute Renal Colic in the Emergency Department". An analgesia protocol for acute renal colic will lead to faster significant reductions in pain than prior practice.
What is the current status of trial NCT00504283?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2007-02. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00504283?
The interventions under investigation include: Morphine (DRUG), Toradol (DRUG).
Who is sponsoring clinical trial NCT00504283?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.